TerminatedNot Applicable

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

Stopped: Principle investigator resigned in 2013

Japan1,500 participantsStarted 2009-04

Plain-language summary

This study is aimed to investigate whether treatment with Telmisartan is more effective than Candesartan in reducing the ischemic cardiovascular events in high-risk patients with cardiovascular disease.

Who can participate

Age range30 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Coronary artery disease documented by at least one of the following:
✓. Peripheral arterial disease undergoing percutaneous transluminal angioplasty (PTA) or peripheral artery bypass grafting at least 6 months before enrollment
✓. Symptomatic cerebral infarction or cerebral hemorrhage at least 6 months before enrollment

Exclusion criteria

✕. History of worsening of heart failure within the preceding 6 months
✕. Planned elective percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) within the anteceding 3 months
✕. History of myocardial infarction, unstable angina pectoris, percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) within the preceding 12 months
✕. History of percutaneous hind limb angioplasty (PTA) or bypass grafting within the preceding 6 months
✕. History of cerebral infarction, cerebral hemorrhage within the past 6 months
✕. Congenital heart disease
✕. Uncontrolled hypertension on treatment (eg, BP\>180/110 mmHg)
✕. Pregnant women or women of childbearing potential

What they're measuring

New or recurrent acute myocardial infarction and angina pectoris

Timeframe: 3 years

Trial details

NCT IDNCT00863980

SponsorKyoto Prefectural University of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-07

View on ClinicalTrials.gov More Acute Myocardial Infarction trials